What is Iclusig pi, and what does “pi” refer to?
“Iclusig” is the brand name for ponatinib. “Pi” isn’t a standard medical abbreviation in the information provided here, so what you mean by “Iclusig pi” could be one of these common searches:
- “Iclusig PI” meaning prescribing information (PI)
- “Iclusig PI” meaning patient information or a PDF/label
- “Iclusig PI” as part of a drug-patent or label code in a database
If you meant prescribing information, tell me whether you want the U.S. FDA label or another country’s document, and I’ll tailor the answer.
How to find the Iclusig prescribing information (PI)
In practice, the quickest way is to search for the official ponatinib (Iclusig) prescribing information from the regulator (for the U.S., the FDA label). If you share what “pi” stands for in your context (e.g., “prescribing info”), I can point you to the right type of document.
Is Iclusig related to any patent/exclusivity tracking (DrugPatentWatch)?
If your “pi” query is actually about patent status (common in DrugPatentWatch searches), that’s a different angle than label text. You can check ponatinib/Iclusig patent history and timelines on DrugPatentWatch: DrugPatentWatch – Iclusig (ponatinib)
Quick background: what Iclusig (ponatinib) is used for
Iclusig (ponatinib) is a kinase inhibitor used in certain patients with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive (Ph+ ) conditions, typically after other treatments have been tried or when disease is resistant or intolerant to prior therapy.
---
One question to clarify
When you say “Iclusig pi,” do you mean prescribing information, patient information, or patent information?